This statistic shows the average street price per gram of cocaine sold in selected Latin American countries in 2016, measured in U.S. dollars. In that year, Cuba registered the highest selling price of cocaine in Latin America, averaging at 56.7 U.S. dollars per gram. The lowest average street price of cocaine was found in Colombia and Bolivia, with 3.5 U.S. dollars per gram.

Compare country statistics and get a global overview for Cocaine Retail Prices.

Between the launch of Eliquis and 2024, the price of the drug in the United States increased by *** percent. This statistic illustrates the price increase of select top-selling drugs in the United States between their launch and 2024.

In 2022, the average price of cocaine in Colombia reached ***** Colombian pesos per kilogram. Meanwhile, cocaine paste was marketed at around ***** pesos per kilogram in 2022.

Graph and download economic data for Index of Wholesale Price of Chemicals and Drugs for United States (M0496AUSM336NNBR) from Jan 1890 to Dec 1951 about medicines, wholesale, chemicals, price index, indexes, price, and USA.

Using the framework of the historical analysis presented to the Senate Subcommittee on Antitrust and Monopoly, drug prices relative to income in the United States are compared to other Organization for Economic Co-Operation and Development (OECD) countries to improve treatment access and affordability.

Countries were selected based on drug price and income data availability and inclusion in the OECD. 40 drugs, 20 brand name and 20 generic, were selected based on revenue sales and prescription volume in 2018. Domestic pricing data included list price, measured by Average Wholesale Price (AWP), and retail price available on GoodRx.com. International drug price data was sourced from publicly available databases on individual country websites.

The first analysis illustrates the percentage of household disposable income needed to cover a year supply of a select product. The second analysis illustrates country-specific difference in drug affordability. The last analysis examines the percent of resources an average family, about three persons, would spend on medication in the United Sates if they were a member of different income groups.

Graph and download economic data for Producer Price Index by Industry: Pharmacies and Drug Retailers: Retailing of Over-the-Counter Drugs (PCU44611044611041) from Jun 2000 to Jul 2025 about medicines, retail, PPI, industry, inflation, price index, indexes, price, and USA.

United States CPI U: AW: Medical Care: CO: Medicinal Drugs (MD) data was reported at 1.797 % in 2017. This records an increase from the previous number of 1.792 % for 2016. United States CPI U: AW: Medical Care: CO: Medicinal Drugs (MD) data is updated yearly, averaging 1.665 % from Dec 2010 (Median) to 2017, with 8 observations. The data reached an all-time high of 1.797 % in 2017 and a record low of 1.554 % in 2010. United States CPI U: AW: Medical Care: CO: Medicinal Drugs (MD) data remains active status in CEIC and is reported by Bureau of Labor Statistics. The data is categorized under Global Database’s USA – Table US.I011: Consumer Price Index: Urban: Weights (Annual).

Graph and download economic data for Nonprescription Drugs Expenditures Price Index (NONDRGPIHCSA) from 2000 to 2021 about nonprescription drugs, medicines, healthcare, health, expenditures, price index, indexes, price, and USA.

Graph and download economic data for Producer Price Index by Commodity: Chemicals and Allied Products: Drugs and Pharmaceuticals (WPS063) from Jan 1967 to Jul 2025 about medicines, pharmaceuticals, chemicals, commodities, PPI, inflation, price index, indexes, price, and USA.

This data package contains UK controlled drugs database, US food prices database, US nationwide food consumption survey, US national health and nutrition examination survey, US healthy eating index and data on food affordability for households led by females.

United States - Producer Price Index by Commodity: Chemicals and Allied Products: Drugs and Pharmaceuticals was 682.88500 Index 1982=100 in July of 2025, according to the United States Federal Reserve. Historically, United States - Producer Price Index by Commodity: Chemicals and Allied Products: Drugs and Pharmaceuticals reached a record high of 686.92800 in December of 2024 and a record low of 47.00000 in January of 1968. Trading Economics provides the current actual value, an historical data chart and related indicators for United States - Producer Price Index by Commodity: Chemicals and Allied Products: Drugs and Pharmaceuticals - last updated from the United States Federal Reserve on August of 2025.

Data on delay or nonreceipt of needed medical care, nonreceipt of needed prescription drugs, or nonreceipt of needed dental care during the past 12 months due to cost by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time. SOURCE: NCHS, National Health Interview Survey, Family Core, Sample Child, and Sample Adult questionnaires. Data for level of difficulty are from the 2010 Quality of Life, 2011-2017 Functioning and Disability, and 2018 Sample Adult questionnaires. For more information on the National Health Interview Survey, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

United States PPI: Chem: Drugs & Pharmaceuticals (Drugs) data was reported at 583.400 1982=100 in Jun 2018. This records an increase from the previous number of 582.900 1982=100 for May 2018. United States PPI: Chem: Drugs & Pharmaceuticals (Drugs) data is updated monthly, averaging 101.700 1982=100 from Jan 1947 (Median) to Jun 2018, with 858 observations. The data reached an all-time high of 583.400 1982=100 in Jun 2018 and a record low of 47.000 1982=100 in Sep 1968. United States PPI: Chem: Drugs & Pharmaceuticals (Drugs) data remains active status in CEIC and is reported by Bureau of Labor Statistics. The data is categorized under Global Database’s USA – Table US.I017: Producer Price Index: By Commodities.

The graph illustrates the most expensive drugs in the United States for the year 2024. The x-axis lists the drug names, including Lenmeldy***, Hemgenix*, Elevidys*, Skysona*, Zynteglo*, Zolgensma*, Myalept**, Danyelza**, Zokinvy**, and Kimmtrak**, while the y-axis represents the cost of each drug in U.S. dollars. Among these, Lenmeldy*** stands as the most costly medication at $4,250,000, followed by Hemgenix* at $3,500,000 and Elevidys* at $3,200,000. The prices gradually decrease with Skysona* priced at $3,000,000, Zynteglo* at $2,800,000, and Zolgensma* at $2,100,000. The remaining drugs—Myalept** ($1,300,000), Danyelza** and Zokinvy** (each at $1,200,000), and Kimmtrak** ($1,100,000)—are comparatively less expensive but still among the highest-priced medications available. The data reveals a significant disparity in drug costs, with the top-priced drug being nearly four times more expensive than the least expensive one listed. This steep decline from the highest to the lowest cost highlights the wide range of prices within the most expensive pharmaceuticals in the U.S. for 2024. The information is effectively represented in a bar graph format, which clearly showcases the differences in drug prices and emphasizes the concentration of costs among the top-tier medications.

In 2022, the brand prescription drugs in the United States were the most expensive in the OECD countries, being over *** times more expensive than in Japan (or *** percent of the price in Japan). In general, the price of branded U.S. prescription drugs was, on average, over *** times more expensive than in other OECD countries.

United States - Producer Price Index by Industry: Pharmacies and Drug Stores: Retailing of Over-the-Counter Drugs was 152.28000 Index Jun 2000=100 in July of 2025, according to the United States Federal Reserve. Historically, United States - Producer Price Index by Industry: Pharmacies and Drug Stores: Retailing of Over-the-Counter Drugs reached a record high of 177.69900 in September of 2023 and a record low of 87.90000 in May of 2005. Trading Economics provides the current actual value, an historical data chart and related indicators for United States - Producer Price Index by Industry: Pharmacies and Drug Stores: Retailing of Over-the-Counter Drugs - last updated from the United States Federal Reserve on August of 2025.

This dataset is comprised of data submitted to HCAI by prescription drug manufacturers for wholesale acquisition cost (WAC) increases that exceed the statutorily-mandated WAC increase threshold of an increase of more than 16% above the WAC of the drug product on December 31 of the calendar year three years prior to the current calendar year. This threshold applies to prescription drug products with a WAC greater than $40 for a course of therapy. Required WAC increase reports are to be submitted to HCAI within a month after the end of the quarter in which the WAC increase went into effect. Please see the statute and regulations for additional information regarding reporting thresholds and report due dates.

Key data elements in this dataset include the National Drug Code (NDC) maintained by the FDA, narrative descriptions of the reasons for the increase in WAC, and the five-year history of WAC increases for the NDC. A WAC Increase Report consists of 27 data elements that have been divided into two separate Excel data sets: Prescription Drug WAC Increase and Prescription Drug WAC Increase – 5 Year History. The datasets include manufacturer WAC Increase Reports received since January 1, 2019. The Prescription Drugs WAC Increase dataset consists of the information submitted by prescription drug manufacturers that pertains to the current WAC increase of a given report, including the amount of the current increase, the WAC after increase, and the effective date of the increase. The Prescription Drugs WAC Increase – 5 Year History dataset consists of the information submitted by prescription drug manufacturers for the data elements that comprise the 5-year history of WAC increases of a given report, including the amount of each increase and their effective dates.

There are 2 types of WAC Increase datasets below: Monthly and Annual. The Monthly datasets include the data in completed reports submitted by manufacturers for calendar year 2025, as of August 8, 2025. The Annual datasets include data in completed reports submitted by manufacturers for the specified year. The datasets may include reports that do not meet the specified minimum thresholds for reporting.

The Quick Guide explaining how to link the information in each data set to form complete reports is here: https://hcai.ca.gov/wp-content/uploads/2024/03/QuickGuide_LinkingTheDatasets.pdf

The program regulations are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/CTRx-Regulations-Text.pdf

The data format and file specifications are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/Format-and-File-Specifications-version-2.0-ada.pdf

DATA NOTES: Due to recent changes in Excel, it is not recommended that you save these files to .csv format. If you do, when importing back into Excel the leading zeros in the NDC number column will be dropped. If you need to save it into a different format other than .xlsx it must be .txt

DATA UPDATES: Annual datasets of reports from the preceding year are reviewed in the second half of the current year to identify if any revisions or additions have been made since the original release of the datasets. If revisions or additions have been found, an update of the datasets will be released. Datasets will be clearly marked with 'Updated' in their titles for convenient identification. Not all datasets may require an updated release. The review of previously released datasets will only be conducted once to determine if an updated release is necessary. Datasets with revisions or additions that may have been made after the one-time review can be requested. These requests should be sent via email to ctrx@hcai.ca.gov. Due to regulatory changes that went into effect April 1, 2024, reports submitted prior to April 1, 2024, will include the data field "Unit Sales Volume in US" and reports submitted on or after April 1, 2024, will instead include "Total Volume of Gross Sales in US Dollars".

Graph and download economic data for Pharmaceutical Products (Without Prescription Drugs) Expenditures Price Index (PHPRDRPIHCSA) from 2000 to 2021 about nonprescription drugs, medicines, pharmaceuticals, healthcare, health, expenditures, price index, indexes, price, and USA.

Graph and download economic data for Producer Price Index by Industry: Drugs and Druggists' Sundries Merchant Wholesalers (PCU4242042420) from Feb 2009 to Jul 2025 about medicines, merchant, wholesale, PPI, industry, price index, indexes, price, and USA.